Islet Holdings Inc. | Balance Sheet

Fiscal year is October-September. All values USD Thousands.
1998
1999
2000
2001
Cash & Short Term Investments
0.00
0.00
61.20
556.20
Total Accounts Receivable
3.00
1.30
0.00
0.00
Inventories
90.30
59.90
25.60
57.60
Total Current Assets
98.60
64.50
87.30
1,108.30
Net Property, Plant & Equipment
62.10
47.80
28.80
39.60
Long-Term Note Receivable
0.00
0.00
0.00
0.00
Intangible Assets
288.60
316.40
263.30
-
Total Assets
521.30
452.00
391.70
1,174.40
ST Debt & Current Portion LT Debt
165.00
129.00
348.20
10.20
Accounts Payable
212.90
201.40
230.90
344.60
Income Tax Payable
-
-
-
0.00
Total Current Liabilities
377.90
330.40
579.10
354.70
Long-Term Debt
93.80
30.80
0.00
0.00
Deferred Taxes
0.00
0.00
0.00
0.00
Common Equity (Total)
49.50
90.80
187.40
819.70
Total Shareholders' Equity
49.50
90.80
187.40
819.70
Total Equity
49.50
90.80
187.40
819.70
Liabilities & Shareholders' Equity
521.30
452.00
391.70
1,174.40
Accumulated Minority Interest
0.00
0.00
0.00
0.00
Non-Equity Reserves
0.00
0.00
-
-
Preferred Stock (Carrying Value)
0.00
0.00
0.00
0.00

About Islet Holdings

View Profile
Address
7609 Ralston Road
Arvada Colorado 80002
United States
Employees -
Website http://www.isletholding.com
Updated 07/08/2019
Islet Holdings Inc. engages in the research, development, and commercialization of patented technologies in the field of transplantation therapy for people with conditions of insulin-dependent diabetes. The company was founded on December 10, 1981 and is headquartered in Arvada, CO. .